Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer

Go back to Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
AGENUS (NASDAQ: AGEN) Delayed: 8.09 +0.60 (8.01%)
Previous Close $7.49    52 Week High $7.49 
Open $7.58    52 Week Low $2.61 
Day High $8.35    P/E N/A 
Day Low $7.58    EPS $-1.10 
Volume 1,517,505       

(NASDAQ: GANX) Delayed: 2.01 +0.03 (1.52%)
Previous Close $1.98    52 Week High
Open $2.00    52 Week Low
Day High $2.05    P/E N/A 
Day Low $1.98    EPS
Volume 277,477